Mersana Therapeutics Stock (NASDAQ: MRSN) stock price, news, charts, stock research, profile.
You can purchase shares of Mersana Therapeutics (NASDAQ:MRSN) through any online brokerage.
Other companies in Mersana Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL) and Inozyme Pharma (NASDAQ:INZY).
Mersana Therapeutics has a consensus price target of $6.38.
The stock price for Mersana Therapeutics (NASDAQ: MRSN) is $1.46 last updated December 23, 2024 at 7:17 PM EST.
There are no upcoming dividends for Mersana Therapeutics.
Mersana Therapeutics’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
There is no upcoming split for Mersana Therapeutics.
Mersana Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.